$CVM - CEL-SCI’s Multikine Head and Neck Cancer
Post# of 25833
(Total Views: 48)
Posted On: 09/03/2025 10:35:44 AM
$CVM - CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline https://finance.yahoo.com/news/cel-sci-multik...;tsrc=twtr
(0)
(0)